Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.
暂无分享,去创建一个
A. Hofman | B. Stricker | A. Vulto | J. Wilson | F. Penning-van Beest | L. Visser | P. D. de Smet | A. A. H. Kasbergen | F. P. Penning-van Beest | J. Wilson | A. Hofman | A. A. Kasbergen
[1] K. Hoffmann,et al. Untersuchungen über die Wirkungsweise der Lactulose (β-Galactosido-Fructose) im Darm , 1964, Klinische Wochenschrift.
[2] S. Schenker,et al. Portal systemic encephalopathy. , 1997, Clinics in liver disease.
[3] P. Thürmann,et al. Clinically Important Drug Interactions with Anticoagulants , 1996, Clinical pharmacokinetics.
[4] J. Vandenbroucke,et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.
[5] J. Hirsh. Oral anticoagulant drugs. , 1991, The New England journal of medicine.
[6] L Goldman,et al. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.
[7] G. Raskob,et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. , 1982, The New England journal of medicine.
[8] D. Hollander,et al. Vitamin K2 colonic and ileal in vivo absorption: bile, fatty acids, and pH effects on transport. , 1977, The American journal of physiology.
[9] D. Hollander,et al. Vitamin K1 intestinal absorption in vivo: influence of luminal contents on transport. , 1977, The American journal of physiology.
[10] A. Dawson,et al. The effect of lactulose on the faecal flora of patients with hepatic encephalopathy. , 1974, Journal of medical microbiology.
[11] D. Mossel,et al. [STUDIES ON THE MECHANISM OF ACTION OF LACTULOSE (BETA-GALACTOSIDE ACTION OF LACTULOSE (BETA-GALACTOSIDO-FRUCTOSE) IN THE INTESTINE]. , 1964, Klinische Wochenschrift.